IL2 and preeclampsia: The extraction process focused on both clinical outcomes, such as the incidence of preeclampsia and related maternal and neonatal complications, and biomarker analyses, including levels of anti-inflammatory markers like 15-epi-lipoxin A4 and IL-2.